Boston Scientific leads M&A funder plunder
The dollar new issuance market enjoyed a hot streak this week, as a series of blue-chip names took advantage of tightening spreads to cram supply into a holiday-shortened week.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts